CoreWeave reports second-quarter 2026 results Tuesday, August 11, after the close, with the conference call set for 5:00pm ET, according to the company's own investor relations announcement. Wall Street's headline numbers are already set. Consensus lands at $2.55 billion in revenue (Benzinga) to $2.56 billion (TipRanks), roughly 108-111% growth against the $1.21 billion CoreWeave posted a year ago. None of that has happened yet, and this article treats it that way throughout.
The number that actually decides if CRWV is worth the pre-earnings risk is not the revenue line. It's remaining performance obligations, the contracted revenue a cloud company has already signed but has not yet recognized because the compute capacity has not been delivered and turned on. CoreWeave's own Q1 2026 release, published around May 7, put that backlog at $99.4 billion. Every mention of that number in this article refers specifically to Q1's figure. No Q2 backlog number exists yet, and treating $99.4 billion as a current or Q2 total would be wrong on its face.
At a Glance Before Tuesday
- Report date and time: Tuesday, August 11, 2026, after market close, call at 5:00pm ET
- Consensus revenue: $2.55 billion (Benzinga) to $2.56 billion (TipRanks)
- Consensus EPS: a loss of $1.17 (Zacks) to $1.27 (TipRanks), a wider spread than usual
- Options-implied post-earnings move: 15.5% (TipRanks, BigGo, Yahoo Finance) versus 12% (Investing.com CA)
- Q1's backlog: $99.4 billion in remaining performance obligations, reported around May 7, 2026
CRWV traded around $91.78 in Monday's pre-market quote. That figure is a level, not a session move. Every stock percentage a live feed shows right now compounds Friday's close forward across the weekend, and reporting one as today's move would misstate what actually happened. With that out of the way, the more useful question is if the backlog math supports the risk of holding into a print with a 15.5% implied swing.
The Event and What's Already Priced In
CoreWeave has already been the subject of four prior pieces on this site, which means a generic preview earns nothing new. What earns its place is doing the arithmetic that most previews skip. Start with what the market has already baked into the stock ahead of Tuesday.
|
Metric
|
Figure
|
Source
|
|
Q2 revenue consensus
|
$2.55B / $2.56B
|
Benzinga / TipRanks
|
|
EPS consensus
|
loss of $1.17 / $1.27
|
Zacks / TipRanks
|
|
Options-implied move
|
15.5% / 12%
|
TipRanks, BigGo, Yahoo / Investing.com CA
|
|
Street price target
|
~$141 / ~$147 (14 analysts) / $127.76
|
our file / Visible Alpha via TipRanks / BigGo
|
|
Q1's backlog (RPO)
|
$99.4B
|
CoreWeave, reported ~May 7, 2026
|
Three different price targets from three different providers is not an error to average away. It is the real picture of a stock where sell-side models disagree by roughly 15% on where fair value sits, before Tuesday's numbers even exist to narrow the gap. The EPS spread tells a similar story. Zacks models a loss of $1.17 a share and TipRanks models $1.27, a wider gap than usual for a stock this closely tracked, which on its own suggests analysts are less confident than the tight revenue consensus implies.
The Backlog-Conversion Math, Shown and Labeled
This is where the article actually earns its place. CoreWeave has told investors that roughly 36% of the backlog converts to revenue within two years and about 75% within four years. Nobody on the sell side appears to have run that guidance against the $99.4 billion figure in plain dollar terms, so the math below is done by us and labeled clearly as our own calculation, since neither CoreWeave nor any covering analyst has published this arithmetic.
Thirty-six percent of $99.4 billion is $35.8 billion. Spread evenly across eight quarters, that averages out to roughly $4.5 billion a quarter. Seventy-five percent of $99.4 billion is $74.6 billion, and spread evenly across sixteen quarters, that averages to roughly $4.7 billion a quarter. Both straight-line averages sit well above the $2.55-2.56 billion consensus expects for the actual Q2 print, and that gap is the whole story most previews miss.
A straight-line average is almost certainly the wrong way to think about how this backlog converts, and the gap itself tells you why. Revenue only shows up once data center capacity is delivered and switched on, not the moment a contract is signed. If CoreWeave is still building out that capacity through 2026, conversion is realistically backloaded toward the later quarters of the two-year and four-year windows rather than smooth from day one. That reading lines up with Wells Fargo's Michael Turrin, who models operating margin near 3% in Q2, 6% in Q3, and 13% in Q4 2026, an estimate that is explicitly his own and not a consensus figure. A margin path that steepens through the year describes a business getting more utilized as capacity comes online, a considerably more realistic picture than a flat conversion rate held constant from day one.
Cantor Fitzgerald's Brett Knoblauch, who rates CRWV a Buy with a $167 price target, expects roughly $40 billion of new Q2 backlog additions, matching the pace CoreWeave set in Q1. Run that number and the answer is it changes very little about Tuesday's print. New commitments signed in Q2 do not convert into Q2 revenue. What a $40 billion addition would do, by our own arithmetic, is push total backlog toward the $130-140 billion range once Q2's roughly $2.55 billion in recognized revenue is netted out. That is a multi-year runway question, not a Tuesday question, and conflating the two is the mistake a generic preview makes.
The Capex and Capacity Constraint
CoreWeave has guided to $31-35 billion in 2026 capital expenditure. Compare that against the roughly $18-19 billion a year our straight-line backlog math implies (the $4.5-4.7 billion quarterly average multiplied by four quarters), and CoreWeave is spending close to double what the flat-line backlog conversion pace would suggest it needs. That gap is consistent with a company building capacity ahead of when the signed contracts actually get recognized as revenue, which supports the view that power availability, GPU delivery schedules, and data center construction timelines are the binding constraint on how fast this backlog becomes revenue, not a shortage of customer demand.
This is why CoreWeave's Nasdaq-100 inclusion earlier this year mattered beyond the index-fund flows. It signaled that institutional investors were underwriting a company whose growth ceiling is set by how fast it can build, not by how many customers it can find. For a wider look at how that capacity race is playing out across the AI infrastructure stack, our comparison of Marvell and Broadcom's AI chip positioning covers the supply-side bottleneck from the silicon side, and our piece on Nvidia's $250 billion Ohio data center guarantee with OpenAI shows the same power and buildout constraint showing up on the customer side of the same trade.
CEO Michael Intrator, whom we profiled separately, has built CoreWeave's entire pitch around being the fastest mover on GPU capacity, a bet that only works if delivery keeps pace with demand. Tuesday's call is the first real test of if that capacity is arriving on the schedule the backlog math assumes, or if the 2026 capex guidance needs to move.
The Analyst Spread and Why It Exists
The three-way split in street price targets, roughly $141 in our own file, roughly $147 across the 14 analysts Visible Alpha tracks via TipRanks, and $127.76 from BigGo, is not noise. It reflects a genuine disagreement about which half of this article's math each analyst weights more heavily. Cantor's Knoblauch, at $167, is pricing the backlog and the $40 billion Q2 addition estimate as the dominant variable, betting that capacity delivery keeps pace with signed demand. Wells Fargo's Turrin is modeling the margin path quarter by quarter, which treats near-term execution and the pace of the capex-to-revenue conversion as the swing factor rather than the backlog total itself.
Both approaches are defensible, and the market's 15.5% implied move (the figure carried by three separate sources, TipRanks, BigGo, and Yahoo Finance, against a lower 12% read from Investing.com CA) says options traders expect Tuesday to move the stock enough to matter for either thesis. A wide implied move ahead of a print with this much disagreement in the underlying models is the market pricing genuine uncertainty about which analyst is closer to right.
What Would Actually Settle the Argument Tuesday
The backlog-conversion math above is a straight-line simplification because CoreWeave has not disclosed a quarter-by-quarter conversion schedule. Three specific disclosures on Tuesday's call would replace that simplification with real data. First, an updated total backlog figure that shows if Q2 additions came in near Cantor's $40 billion estimate or fell short of it. Second, any commentary on if the 36%-in-two-years and 75%-in-four-years conversion ratios still hold, since a revision in either direction changes every number in the math above. Third, capex guidance for the back half of 2026, which would confirm or challenge if $31-35 billion for the full year is still the right range once actual Q2 spending is known.
None of those three data points exist before the call happens, and consensus estimates are not a substitute for them. Anyone treating Tuesday's revenue print in isolation, without checking if the backlog commentary and capex guidance moved in the same direction, is trading the headline number instead of the thing that actually determines if $99.4 billion in contracted revenue turns into cash on a schedule the current stock price assumes.
Frequently Asked Questions
When does CoreWeave report earnings?
CoreWeave reports second-quarter 2026 results on Tuesday, August 11, 2026, after the market close, with the conference call scheduled for 5:00pm ET according to the company's own investor relations announcement.
What is CoreWeave's remaining performance obligations backlog?
CoreWeave reported $99.4 billion in backlog, which the company defines as remaining performance obligations plus other committed customer revenue it expects to recognize in future periods, as of Q1 2026 around May 7, 2026. No updated Q2 figure exists until Tuesday's report.
What is the options market pricing for CoreWeave's earnings move?
Three sources, TipRanks, BigGo, and Yahoo Finance, put the options-implied post-earnings move at 15.5%, while Investing.com CA reports a lower 12% figure. Both figures describe how large a move options traders expect, without predicting which direction it goes.
How much of CoreWeave's backlog converts to revenue?
Management guidance points to roughly 36% of the backlog converting to revenue within two years and about 75% within four years. Applied to the $99.4 billion Q1 figure, that is $35.8 billion and $74.6 billion respectively, though the pace within each window is not disclosed and is unlikely to be a flat, straight-line rate.
Bottom Line
The backlog math shows real tension rather than a clean bull or bear case. Our own straight-line calculation on Q1's $99.4 billion backlog implies quarterly conversion averages of $4.5-4.7 billion, well above the $2.55-2.56 billion Wall Street expects Tuesday, and the $31-35 billion 2026 capex guidance running roughly double the annualized version of that same math points toward capacity, not demand, as the real constraint on how fast this converts to cash. If Tuesday's call confirms Q2 backlog additions near Cantor's $40 billion estimate and holds the 36%/75% conversion guidance, the math above supports the bull case that this is a demand-rich company still ramping supply. If backlog additions fall well short of $40 billion, or if the conversion ratios get walked back, the constraint reframes as weakening demand rather than a supply bottleneck, which is a materially worse setup. Decide before the call if you are trading the print itself, where options price a 15.5% swing, or the multi-year backlog thesis, because Tuesday's numbers will move the first far more than the second.
This article is for informational purposes only and does not constitute financial or investment advice. Cryptocurrency and equity trading involves substantial risk. Always conduct your own research before making trading decisions.
